Early and late determinants of C-reactive protein release in patients with acute coronary syndrome

International Journal of Cardiology

Volumn 112, Issue 1, 2006, Pages 136-138

  Brunetti, Natale Daniele ^a   Pellegrino, Pier Luigi ^a   Correale, Michele ^a   Troccoli, Rossella ^a   Di Biase, Matteo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Acute coronary syndrome (ACS); Atherosclerosis; C reactive protein (CRP)

Indexed keywords

C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; EVALUATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CORONARY CIRCULATION; CORONARY DISEASE; HUMANS; MYOCARDIUM; NECROSIS; RISK FACTORS; TIME FACTORS;

EID: 33747330409     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.001     Document Type: Article

References (33)

1. Jaye D.L., and Waites K.B. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 16 8 (1997) 735-746
2. Otterness I.G. The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24 2 (1994) 91-104
3. Moutsopoulos H.M., Elkon K.B., Mavridis A.K., Acritidis N.C., Hughes G.R., and Pepys M.B. Serum C-reactive protein in primary Sjogren's syndrome. Clin Exp Rheumatol 1 1 (1983) 57-58
4. Mazlam M.Z., and Hodgson H.J.F. Interrelations between interleukin-6, interleukin-1b, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 35 (1994) 77-83
5. Brunetti N.D., Troccoli R., Correale M., Pellegrino P.L., and Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol (2005) [Epub ahead of print]
6. Cusack M.R., Marber M.S., Lambiase P.D., Bucknall C.A., and Redwood S.R. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 39 12 (June 19 2002) 1917-1923
7. Tommasi S., Carluccio E., Bentivoglio M., et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 83 (1999) 1595-1599
8. Nikfardjam M., Mullner M., Schreiber W., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 247 (2000) 341-345
9. Suleiman M., Aronson D., Reisner S.A., et al. Admission C-reactive protein levels and 30-day 538 mortality in patients with acute myocardial infarction. Am J Med 539 115 (2003) 695-701
10. Zebrack J.S., Anderson J.L., Maycock C.A., Horne B.D., Bair T.L., and Muhlestein J.B. for the Intermountain Heart Collaborative (IHC) Study Group. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 89 (2002) 145-149
11. Speidl W.S., Graf S., and Hornykewycz S. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 144 (2002) 449-455
12. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169 2 (August 2003) 203-214
13. Avanzas P., Arroyo-Espliguero R., Cosìn-Sales J., Quiles J., Zouridakis E., and Kaski J.C. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175 (2004) 151-157
14. Vainas T., Stassen F.R.M., and de Graaf R. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 (2005) 243-251
15. Haverkate F., Thompson S.G., and Pepys M.B. the ECAT Angina Pectoris Group. C-reactive protein and cardiovascular disease fibrinolysis and proteolysis. Supplement 11 1 (April 1997) 133-134
16. Lakoski S.G., Cushman M., Palmas W., Blumenthal R., D'Agostino R.B., and Herrington D.M. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 46 (2005) 1869-1874
17. Arroyo-Espliguero R., Avanzas P., Cosýn-Sales J., Aldama G., Pizzi C., and Kaski J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25 (2004) 401-408
18. Tanaka A., Shimada K., and Sano T. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 45 (2005) 1594-1599
19. Sano T., Tanaka A., Namba M., et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 108 (2003) 282-285
20. Stefanadis C., Diamantopoulos L., Dernellis J., et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 32 (2000) 43-52
21. Inoue T., Kato T., Uchida T., et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 46 (2005) 239-245
22. Celik T., Iyisoy A., Kursaklioglu H., Turhan H., and Isik E. Does the pre-existing inflammation play a role in the increased C-reactive protein levels in acute myocardial infarction?. Int J Cardiol 112 (2006) 134-135
23. Berton G., Cordiano R., Calmieri R., Pianca S., Pagliata V., and Palatini P. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J 145 (2003) 1094-1101
24. Brevetti G., Silvestro A., Di Giacomo S., et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38 (2003) 374-379
25. Zairis M.N., Manousakis S.J., Stefanidis A.S., et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 144 (2002) 782-789
26. Hoffmann R., Suliman H., Haager P., et al. Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. Atherosclerosis (2005) [Epub ahead of print]
27. Roumen-Klappe E.M., den Heijer M., van Uum S.H.M., et al. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 35 (2002) 701-706
28. Ercan E., Tengiz I., Duman C., Onbasili A., and Baris N. Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction. Am Heart J (2004) 147-151
29. Amasyali B., Kosea S., Kilic A., et al. C-Reactive protein on admission and the success of thrombolytic therapy with streptokinase: is there any relation?. Int J Cardiol 92 (2003) 27-33
30. Speidl W.S., Zeiner A., Nikfardjam M., et al. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion. J Am Coll Cardiol 45 (2005) 30-34
31. Retterstol A., Eikvar L., and Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169 (2003) 279-282
32. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
33. Rahel B.M., Visseren F.L.J., Suttorp M.J., et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res 60 (2003) 136-140